{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T23:03:57Z","timestamp":1771887837673,"version":"3.50.1"},"reference-count":0,"publisher":"Pasifika Medical Association Group","issue":"1630","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NZMJ"],"abstract":"<jats:p>Persistent inequities in cancer outcomes for M\u0101ori and Pacific peoples remain one of the most significant challenges facing the\nAotearoa New Zealand health system. These disparities are evident across incidence, stage at diagnosis, access to treatment and\nsurvival. While often attributed to behavioural risk factors, the predominant drivers are structural, including barriers to access, health\nsystem design, workforce limitations and broader socio-economic determinants. Despite long-standing recognition, progress has been\ninconsistent and insufficient. Addressing these inequities requires a shift from description to accountability, with equity embedded\nas a core performance metric. Culturally aligned services, improved access to care, strengthened primary care and the use of registrybased\ndata to drive quality improvement are essential components of a system capable of delivering equitable outcomes. Comprehensive\ncancer centres could offer a further opportunity to reduce variation and improve access to high-quality multidisciplinary care. In parallel,\nscreening policy must better reflect epidemiological realities, including the earlier onset of colorectal cancer among M\u0101ori. Equity\nin cancer care is fundamental to the definition of a high-performing health system. Without measurable progress, equity remains\ndeferred\u2014and therefore denied.<\/jats:p>","DOI":"10.26635\/6965.e1630","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T22:26:06Z","timestamp":1771885566000},"page":"9-12","source":"Crossref","is-referenced-by-count":0,"title":["Equity deferred is equity denied: cancer outcomes for M\u0101ori and Pacific peoples"],"prefix":"10.26635","volume":"139","author":[{"given":"Frank","family":"Frizelle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11177","published-online":{"date-parts":[[2026,2,27]]},"container-title":["New Zealand Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T22:26:06Z","timestamp":1771885566000},"score":1,"resource":{"primary":{"URL":"https:\/\/nzmj.org.nz\/journal\/vol-139-no-1630\/equity-deferred-is-equity-denied-cancer-outcomes-for-maori-and-pacific-peoples"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":0,"journal-issue":{"issue":"1630","published-online":{"date-parts":[[2026,2,27]]}},"URL":"https:\/\/doi.org\/10.26635\/6965.e1630","relation":{},"ISSN":["1175-8716"],"issn-type":[{"value":"1175-8716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]}}}